Status:
UNKNOWN
Treatment Modalities of Oral Lichen Planus
Lead Sponsor:
University of Faisalabad
Conditions:
Oral Lichen Planus
Eligibility:
All Genders
Phase:
EARLY_PHASE1
Brief Summary
Background: Oral lichen planus (OLP) is a chronic inflammatory mucocutaneous autoimmune disease mainly affecting stratum basal of the epithelium. It is very painful and hamper the daily routine of pat...
Detailed Description
Introduction Oral lichen planus (OLP) is a chronic inflammatory mucocutaneous autoimmune disease mainly affecting stratum basal of the epithelium. It is T-cell mediated immunological disease that most...
Eligibility Criteria
Inclusion
- \- 1. Histopathologically proven patients of OLP of all age groups complaining of symptoms such as pain, burning sensitivity to hot and spicy food.
- 2\. Who have signed informed consent.
Exclusion
- \- 1. Patients who have taken any medication for OLP within 4 weeks before the start of study.
- 2\. Pregnant and lactating women. 3. History of lichenoid reactions to beta blockers, dapsone, oral hypoglycemics, NSAIDS, pencillamine, phenothiazines, sulfonylureas, gold salts or amalgam fillings.
Key Trial Info
Start Date :
June 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2017
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT03237533
Start Date
June 1 2017
End Date
December 31 2017
Last Update
August 2 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The university of Faisalabad
Faisalabad, Punjab Province, Pakistan, 38000